ALOQUEN
DEAD

Serial Number

90730427

Owner

AICURE CORPORATION

Attorney

Kristen McCallion

Filing Date

May 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ALOQUEN Trademark

Serial Number: 90730427

ALOQUEN is a trademark filed by AICURE CORPORATION on May 24, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AICURE CORPORATION (4 trademarks)

4201 MAIN STREET
HOUSTON, TX 77002

Entity Type: 03

AIC Innovations Group, Inc. (10 trademarks)

902 Broadway, 6th Floor
New York, NY 10010

Entity Type: 03

Trademark Details

Filing Date

May 24, 2021

Registration Date

Not Registered

Published for Opposition

August 9, 2022

Goods & Services

Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SAAS) services, featuring software for administering medication adherence programs, monitoring patient behavior, and enabling remote patient engagement to enable health care providers,clinical trial personnel, and clinical trial sponsors; providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in database management for use in drug development and analysis; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology

Providing medical analysis services relating to the treatment of persons, namely, monitoring medication intake for purposes of analyzing medical treatment adherence; medical services being patient medication care management and medication adherence services, namely, communicating with patients regarding their medications and adherence to medication regimens for medical treatment and clinical research purposes; medication adherence programs, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage for medical treatment and clinical research purposes; providing medical information and medical monitoring information from remote locations via the Internet and telecommunication networks via patient monitoring devices that feed information to a website that can be accessed in real-time by medical professionals; providing a website featuring medical information in the nature of an online medical profile and medical record analysis service designed to provide patients and medical professionals with custom tailored information regarding medication adherence; medical services, namely, providing interactive medical monitoring and alert service for reminding patients of medication dosages and medication adherence for medical treatment and clinical research purposes

Downloadable computer application software for managing, administering, and monitoring medication adherence; downloadable computer application software for monitoring patient behavior; downloadable computer software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; electronic downloadable publications in the nature of data files, findings in the nature of papers and reports, evaluations in the nature of papers and reports, and reports in the field of medicine and pharmacology

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 21, 2026 ASGN
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 14, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 14, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2024 EXRA
SOU EXTENSION 4 GRANTED
Sep 25, 2024 EX4G
SOU EXTENSION 4 FILED
Sep 25, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2024 EXRA
SOU EXTENSION 3 GRANTED
Mar 7, 2024 EX3G
SOU EXTENSION 3 FILED
Mar 7, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 7, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2023 EXRA
SOU EXTENSION 2 GRANTED
Oct 3, 2023 EX2G
SOU EXTENSION 2 FILED
Oct 3, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 3, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 1, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 1, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 1, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 4, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 9, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 9, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 15, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 15, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2021 NWOS
NEW APPLICATION ENTERED
May 27, 2021 NWAP